|||**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**|**Trustees' Annual Report for theperiod**| |---|---|---|---|---|---|---|---|---|---| ||**From**|Period start date||||**To**|Period end date||| ||||||||||| |||1st||January|2024||31st|December|2024| ||||||||||| |Section A||Reference and administration details|||||||| |**Charity name**
**Registered charity number**
**Charity's principal address**|||||||||| ||||Tissue Viability Society (TVS)
known as Society of Tissue Viability||||||| ||||||||||| ||||1180844||||||| ||||||||||| ||||c/o The Clinical Trials Research Unit, University of Leeds,
Leeds LS2 9JT||||||| ## **Names of the charity trustees who manage the charity. Trustees are elected by the council or members.** ||**Trustee name**|**Office (if any)**|**Dates acted if not for whole year**| |---|---|---|---| |1.|Sarah Gardner|Chair|Since 2018, Chair since September 2023| |2.|Sharon Neill|Vice Chair|Since 2020, Vice Chair since September 2024| |3.|David Hibbitt|Treasurer
Industryrepresentative|Since 2018, Treasurer since July 2022| |4.|Kate Williams|Vice Treasurer, Legs
Matter lead|Since 2018, Vice Treasurer since July 2022| |5.|Sarah Bradbury||Since 2024| |6.|Srinivasa Budithi||Since 2022| |7.|Luxmi Dhoonmoon||Since 2024| |8.|Ina Farrelly||Since 2019| |9.|Madeleine Flanagan||Since 2023| |10.|Clare Greenwood||Since 2021| |11.|Julie Hewish||Since 2024| |12.|Ayesha Marshall||Since 2023| |13.|Victoria Murray|Industryrepresentative|Since 2021| |14.|Inês Pereira||Since 2024| |15.|Samantha Rooney||Since 2022| |16.|Sharon Scattergood||Since 2022| |17.|Joanna Swan||Since 2018| |18.|Peter Worsley||Since 2022| Society of Tissue Viability Annual Report 1 August 2025 ## **Section B Structure, governance and management** ## **Description of the charity’s trusts** Type of governing Constitution document How the charity is A Council of Trustees constituted Trustee selection methods Appointed by Council or elected by membership depending upon number of available places and number of applicants. ## **Section C Objectives and activities** The objectives for which the Society is established are to promote learning and advance public education in the study of tissue viability and **Summary of the objects of** do all such things as may be conducive to improve standards in tissue **the charity set out in its** viability as a multi-professional activity. **governing document** _All Trustees are aware of the public benefit guidance issued by the Charity Commission and have had regard to this when making decisions to undertake activities._ In 2024 the Society did not hold its own annual conference but was once again delighted to be the partnering organisation for the European Wound Management Association conference (#EWMA2024), 1–3 May at the ExCel London. This event was originally scheduled to take place in 2020 but unfortunately had to be cancelled due to the Covid pandemic. Trustees launched the London 2024 countdown with a sponsored walk spanning the 746 miles from Milan (the location of EWMA 23) to London, with some enthusiastic participants even making the return trip. The walk raised a total of just under £900 in sponsorship. **Summary of the main activities undertaken for** The EWMA conference is nearly ten times the size of the Society’s **the public benefit in** annual conference and London 2024 was attended by just under 5,000 **relation to these objects** delegates from 94 countries. The theme for the conference was Collaborative and sustainable wound care: making everyone’s contribution count, echoing a consensus that the delivery of safe, highquality wound care depends on shared learning, research and innovation in Europe and across the globe. In the run up to the conference, the Society and EWMA jointly promoted the Proud to Make a Difference campaign, encouraging wound care professionals to share their stories through photos and videos to showcase their pride in their work and the impact they have on patients' lives. Participants’ entries were displayed at the conference and two winners each received free registration for either EWMA 25 or SoTV 25. Throughout the year, the Society runs online study days, complemented - by sponsored and Society led webinars. As a Society, we try to target Society of Tissue Viability Annual Report 2 August 2025 education based on need and try to identify service areas that can find it difficult to access education, such as children’s services or those working in mental health settings. We strive to develop our educational programme so that it is collaborative and multidisciplinary, something which is very much reflected in the wide range of clinicians attending our education sessions. A major change for 2024 was the decision to transition the Journal of Tissue Viability (JTV) from a largely subscription only model to full open access, in which all published articles are freely accessible to all. In making this decision, Trustees conducted a lengthy consultation with members, our publisher, editor and editorial board. They took into account the increasing popularity of publishing articles open access in the JTV (37% in 2023), the substantial benefits of open access to wound care professionals in sharing expertise more widely, the increased trend among members requesting not to receive a hard copy of the journal, and the environmental impact of the JTV (printing and despatching a physical journal are its biggest contributors to carbon emissions) by switching to a digital format. In making this change, the SoTV committed to supporting a generous waiving and discounting policy (meaning some authors do not need to pay) to ensure that publishing in the JTV is accessible to all. From 1 January 2025, the JTV transitioned to Gold Open Access and became available in digital form only. _Below is a short summary providing further detail of the main activities the Society has undertaken in 2024 in support of its strategic objectives._ **1. Membership** Being a member of the Society of Tissue Viability means joining a community of some of the world’s best clinical experts and helping to shape and contribute to the science and research of skin health and wound healing. The Society was set up for all those who are passionate about solving skin and wound challenges and we welcome anyone who is interested in skin health and wound healing – whether professionally or personally. Over the course of 2024, the Society continued to attract new members and by April 2025 our membership stood at 1,152. Many members are nurses, but our community also includes doctors, pharmacists, bioengineers, podiatrists, other allied health professionals, academics, researchers, clinical scientists and healthcare industry professionals and it is this diversity in our community that is one of our main strengths. The Society aims to be a voice for its members on a national and international stage. In May 2024, the National Wound Care Strategy Programme’s (NWCSP) change in approach to pressure ulcer categorisation aroused a lot of comment. To reflect the opinions voiced within the Society, Trustees felt it was important to clarify the Society’s standpoint and in July we published a position statement in response to members’ concerns. In the position statement, published on the Society’s website, social media and newsletter, the Society outlined why it was not able to support the change to pressure ulcer categorisation. In a member consultation, 72% of responses received were in agreement with the position statement. Our Active Associate initiative also continued to attract new members in 2024. The initiative was set up to give members the opportunity to become more involved in the work of the Society. Together with our Alumni (former Trustees who remain actively engaged with the Society), Society of Tissue Viability Annual Report 3 August 2025 |Active Associates make up our Associate Forum. We currently have over| |---| |30 Active Associates, several of whom participate in the Society’s work| |streams and educational programmes and in 2024 three Active| |Associates went on to take up roles on the Society’s Council of Trustees.| |The Society’s website has a dedicated member resource area which| |contains a huge amount of fantastic content, including recorded| |presentations from our conferences and our advanced, service specific| |and specialist study days. New content has continued to be added| |throughout 2024 and there is also direct online access to the_Journal of_| |_Tissue Viability,_giving members access to back issues of the JTV| |following its transition to open access at the start of the 2025.| |In addition to our general e-newsletter, we also send out member only| |newsletters so that members are the first to hear about new events and| |Society initiatives. Open rates range between over 42 and 65%| |demonstrating a high engagement rate from our committed audience.| |In 2024 the Society awarded its first Dan Bader Memorial Award, set up| |in memory of Professor Dan Bader, Emeritus Editor of the_Journal of_| |_Tissue Viability_. The award is open to members only and is intended to| |support a healthcare worker, or an early career researcher to develop| |knowledge or best practice within the field of tissue viability, with| |members invited to apply for either a practice development award or a| |research award. The first awards were judged in January 2024 and the| |winners invited to attend the Society’s stream at EWMA 2024 in London.| |Members are also able to apply for grants to attend the EWMA and| |EPUAP European conferences. Being the co-operating partner for| |EWMA 2024 in London, the Society greatly increased the number of| |bursaries available to members from the UK and Ireland and awarded| |175 grants to cover travel costs and, for many, accommodation as well.| |The Society received 23 applications for EPUAP 24 in Lausanne and| |awarded two funded places for members to attend.| |**2. Conference**| |In 2024 the Society was the partnering organisation for the European| |Wound Management Association conference (#EWMA2024), 1–3 May at| |the ExCel London.| |Running alongside the EWMA programme, the Society held its own| |streams:| |•
Wounds Research Network – bringing together the UK's skin health| |and wound research community| |•
Society of Tissue Viability – Collaboration not silos: how everyone’s| |contribution makes a difference to wound care| |•
Student Day – multi-professional student guidance on navigating an| |international conference| |•
Community Healthcare Day – The future of wound care in our| |communities rests in the hands of those who design and deliver care| |The Society offered free places to local attendees and bursaries for| |Society members, totalling:| |171
Free places| |104
Free places and travel bursaries for Society members| |71
Free places and hotel and travel bursaries for Society members| Society of Tissue Viability Annual Report August 2025 4 In total, the EWMA conference attracted 4,995 participants, 165 exhibitors and represented 94 nationalities. The event was a great success for the Society and gave us learnings and ideas to build upon for our 2025 Conference which took place on 30 April–1 May in Bradford. ## **3. Education and Resources** One of the Society’s key aims is to provide education, information and professional development for all health and social care professionals working in skin health and wound healing. The Society’s programme of activities throughout the year has included: ## **Study sessions and online educational events** In 2024 our online events proved successful and by inviting industry dedicated time within the programme and enhancing post event reporting, the events were more attractive, accessible and engaging for our audience. Subjects included: - Fundamentals of lower limb and foot care, pressure ulcer care and wound assessment and management - Advances in lower limb and foot care - Advances in pressure ulcer care and management when caring for people with complex health needs - Advances in wound care - Skin health and wound care for children - Skin health and wound care for older people - Skin health and wound healing in oncology and palliative care settings During 2024, across all our online events (Fundamentals, Advanced and Service specific/Specialist) we educated a total of 1,749 health care professionals, which was a 2.3% increase on 2023. From January to June 2025, we have so far educated a total of 1,255 health care professionals. ## **Webinars** The Society held the following webinars in 2024: - 21 November 2024 from the SoTV in partnership with #4Nations for Stop the Pressure – Pressure ulcer prevention in people with dementia (112 views by 19/6/25) - 19 November 2024 from the SoTV in partnership with #4Nations for Stop the Pressure – Pressure ulcer prevention for people with Learning Disability (133 views by 19/6/25) All webinars are continuing to get views on the Society’s website and YouTube channel and the Society is planning more of their own webinars for 2025 as well as being in discussion for hosting webinars with external organisations so that we can continue to provide this valuable learning opportunity. ## **Skin Care Champions** The Society created the Skin Care Champions programme to provide people working in care homes and home care agencies with trusted, cost-effective and easily accessible education that supports skin health and wound healing. Our ambition is to create and empower a Skin Care Champion for every care home or agency that joins the programme – someone who can help to make sure that excellent care is provided to their clients and residents and be seen as a source of information and knowledge for their peers. Society of Tissue Viability Annual Report August 2025 5 The Society were delighted to be able to continue the programme in 2024 and began its fourth cohort in May with 51 champions (including one midwife from an NHS provider) from 21 provider organisations enrolled. 30 champions regularly attended the monthly meetings. Meeting recordings and module information continued to be viewed and downloaded regularly. The programme was once again very well evaluated with participants particularly appreciating the supportive community of like-minded people and the opportunity to share experiences with the network. Knowledge, skills and confidence questionnaires saw a range of percentage score increase, ranging from 10 to 792%. A fifth cohort of Skin Care Champions started in May 2025 and so far the programme has 99 champions registered from 24 providers, most of which are care homes both residential and nursing. 2025 will be the first year the programme aims to be self-funding. Qualitative feedback from cohort 4 champions was positive and included: • Thank you so much I have learned a lot and been able to use what I have learned in my job already • Thank you for the last year. I have enjoyed this programme and found the information and knowledge fundamental to my role. Looking forward to supporting our link practitioners through it • I have been empowered and educated to support many care homes and home care companies to become involved in the delivery of excellent skin care to their residents and service users. To encourage social care staff to have the confidence to step forward to complete this fantastic course, to truly ignite skin care within social care • I have found all areas that have been discussed interesting and sharing information has been good. I enjoyed the skin tear and the leg modules **Education Endorsement** A core part of the Society’s mission is to make sure that the best new thinking and practice in skin health and wound healing reaches the people it needs to. Our offering of Education Endorsement is a part of fulfilling this. We are proud to work with our industry partners and other not-for-profit organisations to help bring more high-quality, independent education to people with an interest in skin health and wound healing. During 2024 we endorsed nine educational modules/courses for three organisations and so far during 2025, we have endorsed two modules for one organisation, with more being planned. **Revised Seating Guidelines** In 2024 the Society fully revised its Seating Guidelines, co-authored by Melanie Stephens (Reader in Adult Nursing at University of Salford) and Carol Bartley (Occupational Therapist and Educator), alongside several of the Society’s own Trustees. The aim was to provide an essential reference for healthcare professionals, care givers and individuals who remain seated for prolonged periods across all sectors of health and social care. Society of Tissue Viability Annual Report 6 August 2025 The revised guidelines provide a comprehensive resource based on the latest research and evidence surrounding pressure ulcer prevention and management alongside key stakeholder priorities. A survey of nurses and AHPs ascertaining their priorities in seating was conducted (receiving 167 responses) and the final document was sent out to patient and clinical reviewers. The revised Seating Guidelines were published open access in the JTV and launched at the Society’s 2025 annual conference in Bradford. How to practically apply these guidelines was explored in the Society’s webinar, Understanding the association between pressure ulcers and sitting in adults: What does it mean for all of us? in June 2025. **4. Collaborations / Consultations** The Society is regularly approached by external organisations nationally to offer opinion or consultation on work they may be doing. Largely this kind of work is undertaken without consulting the membership, but we are always mindful that we represent our membership when we respond. Collaborations and consultations this year have included: **Legs Matter** : Legs Matter operates under the governance of the Society of Tissue Viability and is a coalition of healthcare organisations that work together to increase awareness, understanding and prevent harm for lower leg and foot conditions. Throughout 2024 and into 2025, there has been good engagement from all coalition partners, with their active participation in meetings and outreach events, and excellent support from the team at PINK, who provide the campaign’s administrative function. Legs Matter also continues to receive great support from Industry through corporate sponsorship and their contribution to the campaign’s strategy. Legs Matter is fortunate to have this financial support, since without it the campaign would not be able to continue. At the time of writing this report, Legs Matter is in a positive financial position. Legs Matter website (legsmatter.org) remained extremely popular, with almost half a million page views during 2024. Over 1,000 page views were recorded on most days, particularly during Legs Matter Week. The top 10 pages were: 1. Cellulitis 2. Oedema and lymphoedema 3. Haemosiderin 4. Home page 5. Cramp 6. Lipoedema 7. Venous hypertension / insufficiency 8. Dermatitis / dry and itchy skin 9. Venous leg ulcers 10. Why is my leg ulcer not healing? Following the theme of 2023, Legs Matter Week from the 10–14 June 2024 focused again on raising the alarm on the hidden harm crisis in leg and foot care, highlighting that people with leg and foot conditions are currently not being treated adequately or in time and, as a result, are being harmed. The awareness week’s programme of events included: Society of Tissue Viability Annual Report August 2025 7 - Inaugural Changemaker award ceremony, set up to celebrate people who are making a difference to end the hidden harm crisis - • Society of Tissue Viability Fundamentals of Lower Limb Study Day - • Barriers to maintaining leg health – Necessary care, right products, right time in partnership with Haddenham Healthcare - Oxygen Therapy in Diabetes Wound care in partnership with AOTI - • Society of Tissue Viability Advanced Study Day in lower limb and foot care - • Where is the harm? Common myths in lower limb care hosted by the Society of Vascular Nurses Launched at the start of Legs Matter Week 2024 was the Legs Matter Roadshow, a national series of events continuing into 2025 aimed at podiatrists and community nurses to promote a consistent multidisciplinary approach in the prevention and treatment of venous disease and oedema. The roadshows have proved incredibly popular and received excellent feedback from delegates. In 2025, as the campaign enters its seventh year of action, its aim is to bring more health and social care professionals into the movement, alongside a more strategic approach to affect the systemic change that is needed to end harm in lower limb care. ## **SToP the Pressure:** The Society once again collaborated with the National Wound Care Strategy Programme (NWCSP) and all #4nations in 2024 for SToP the Pressure week with representatives from England, Scotland, Wales and Northern Ireland. Our media partners, Mark Allen Group and Wounds UK also supported the campaign. Our theme for 2024 was inclusivity ‘Are we really looking, are we really listening’ and asked the following questions: - Might you need to adjust your communication style? Consider the needs of your colleagues and patients when communicating. Everyone “hears” / learns differently - Might you need to adjust or simplify your messages? Information can be overwhelming for many reasons and can be difficult to process - Might you need to consider your environment? Background / environmental constraints may be very distracting Some of the key elements of the campaign were: - A month-long social media campaign with a full ‘social media pack’ of downloadable assets and ideas to enable everyone to join us - • Producing a range of resources, including Top Tips, a range of easyto-read Pressure Ulcer leaflets in a variety of languages to download and links signposting people to help them support the campaign - • Virtual events including a full day of Advances in pressure ulcer care and management when caring for people with complex health needs, a Fundamentals of pressure ulcer care training, a Pressure ulcer prevention in people with dementia webinar and a Pressure ulcer prevention for people with learning disability webinar (see previous webinar section) - • Providing a range of activities and competitions including a #STOPTHEPRESSURE quiz and word search Society of Tissue Viability Annual Report 8 August 2025 • Designing a range of downloadable assets including posters, banner stands and selfie frames • Industry support from Accora, Arjo, Essity, Drive Devilbiss, Isla Health and Medstrom The videos and assets were uploaded to the Resource section of the Society’s website and are available on an ongoing basis. Work has already commenced on the 2025 campaign and once again it is a #4Nation collaboration and we will be reaching out to our industry partners to gain support. **Wounds Research Network (WReN):** After successfully changing the format of WReN’s annual meeting in 2023 by adding a concurrent research stream at our annual conference, this was replicated during the EWMA/SoTV joint conference in 2024, where we held a separate stream lead by the Wounds Research Network, bringing together the UK's skin health and wound research community. The sessions attracted a good audience and was a popular choice for EMWA delegates. **Nurses Specialized in Wound, Ostomy and Continence Canada (NSWOCC):** In 2024 the Society continued collaborative working with NSWOCC around producing a joint consensus document on best practice in relation to sharp debridement. The SoTV published 15 primary statements produced by the collaboration open access in July 2024 in the JTV article _The development of international Wound Debridement Best Practice Recommendations: Consensus between Nurses Specialized in Wound, Ostomy and Continence Canada and the Society of Tissue Viability_ thereby making the work freely open for all to share. **International Skin Tear Advisory Panel (ISTAP):** The Society has a memorandum of understanding with the International Skin Tear Advisory Panel to raise awareness about the prevention and management of skin tears and skin breakdown. In 2024 ISTAP contributed to our Skin Care Champions programme by presenting a talk to our 2024 cohort on skin tears and the Society promoted ISTAP’s a World Without Skin Tears day in April 2024. **Loose Skin after Weight Loss:** In association with the British Dietetic Association, the Society was asked to contribute to a patient resource to support aftercare for those who had undergone bariatric surgery or experienced excessive weight loss. With no advice currently available, the Society agreed to provide guidance on skin health and maintaining skin elasticity and integrity. Completed in 2025, the Society hopes that this will prove an informative and relevant resource. **Professional Records Standards Body (PRSB)** The PRSB was set up to develop clinical standards for health and care records, by identifying a critical set of information needed for safe and high-quality care that can be integrated into electronic systems. In 2023 the PRSB approached the Society to endorse their Wound Care Information Standard which covers three key domains: wound assessment and treatment; treatment plan; and supported self-care. After consultation, the Society agreed to endorse the Wound Care Information Standard in 2024. Society of Tissue Viability Annual Report 9 August 2025 **British Healthcare Trades Association (BHTA)** : In 2024 the BHTA approached the Society to work on raising awareness among prescribers and procurement departments on the standards and objective measures that should be considered when procuring equipment, specifically with regard to beds, support surfaces and seating. The Society worked on demystifying the standards and in June 2025 published a series of blogs Cutting Through the Confusion: Understanding Standards for Beds and Mattresses. The Society also held a webinar in March 2025 on Pressure ulcer treatment versus fire risk for clinicians and procurers involved in the care of patients who smoke and require equipment for pressure relief. **5. Journal of Tissue Viability** The Society’s journal, the _Journal of Tissue Viability_ (JTV), is a high quality, peer reviewed journal that has an international readership. During 2024 the Society explored transforming the JTV to becoming online only and open access in pursuit of the Society’s aim of sharing information and research as freely as possible. After extensive consultation and discussion, the decision was taken to move forward with this transformation and in January 2025 the JTV transitioned to a Gold Open Access publishing model, whereby articles published from 2025 onward are freely and immediately accessible to readers. The Gold Open Access business model is primarily supported through author publication fees. This business model offers several benefits, including increased visibility and wider dissemination of research, regardless of institutional or individual subscription access. Editorial and need-based waivers are available for authors without funding to support the Article Processing Charge (APC) and SoTV members receive a discount on APCs for publishing their research in the JTV. In 2024 the JTV received over 400 manuscript submissions. Following the shift to the new business model, submission volumes decreased in the first half of 2025, aligning with expectations. Despite the reduction in quantity, the quality of submissions remained high, with a rejection rate of 61% in 2024. The journal continues to see a growing share of submissions from Asia. In 2024, the JTV recorded over 300,000 full-text article accesses. Following the transition to a Gold Open Access model in 2025, this figure has increased by approximately 70% year to date, reflecting a significant rise in readership and accessibility. The journal’s impact factor improved in 2024 reaching 2.8 (2.4 in 2023) and outperforming many similarly cited journals. Impact factor is a measure of the number of times an average paper in a journal is cited during a year and is used to measure the importance of a journal, and often used for the evaluation of research and researchers. In 2024, the JTV ranked 31st (second quartile) in dermatology and 25th (first quartile) in nursing, indicating strong relative performance within these fields. ## **6. Wider public engagement and public benefit** The Society contracts PINK Marketing to support its wider administrative needs including conference organisation, involvement in strategy and projects and managing its digital presence. For the sponsorship year 1 June 2024 to 31 May 2025, PINK secured support Society of Tissue Viability Annual Report 10 August 2025 from 15 industry sponsors to provide financial support as corporate partners for the Society. The PINK team manages the Society’s social media accounts. By 31 December 2024, followers of the Society’s X (formerly Twitter) account had increased to 7,353 (up by 1.7%), Facebook to 5,816 followers (up 2.1%), LinkedIn to 2,997 (up 22%) and Instagram increased to 496 followers (up 32%). In addition, at the end of 2024 there were 5,014 people subscribed to receive the Society’s informative e-newsletter. We consistently had open rates ranging from high 20s to early 30s percent, with our highest open rate being 47.9% during Legs Matter week. The SoTV website attracted more than a quarter of a million page views during 2024 with almost 75,000 active users and an average engagement time per active user of 1 minute 17 seconds. We continue to have more than 1,000 page views on most weekdays. Our top 10 pages visited during 2024 were: 1. Home page 2. Member log in 3. Stop the Pressure 4. Education and learning 5. Free educational sessions 6. What’s on 7. Resources 8. EWMA/SoTV 2024 Joint Conference 9. Research and resources 10. Fundamental educational sessions ## Section D Achievements and performance **Summary of the main achievements of the charity during the year** ## **Highlights of the Society’s achievements in 2024:** - **Membership** : the Society’s membership grew to over 1,150 and Active Associates took up positions on the Council of Trustees; the first Dan Bader Memorial Awards were presented; the Society published a position statement in response to members’ concerns about the changes to pressure ulcer categorisation in England. - **2024 EWMA conference:** the Society was the co-operating partner for a very successful EWMA conference in London, which attracting nearly 5,000 delegates. The Society ran four streams alongside the main EWMA programme. - **Study sessions** : changes to the format made our online events more attractive, accessible and engaging for our audience. - **Skin Care Champions** A fourth cohort of Skin Care Champions was launched to support and provide trusted, easily accessible skin health and wound healing education to carers in domiciliary and care home settings; 51 champions took part. - **Education Endorsement** : in 2024 our Education Endorsement service, which aims to review generic educational materials provided by our industry partners to ensure quality for users across the UK, endorsed modules from 3 organisations. - **Legs Matter** : the 2024 Legs Matter awareness week continued to focus on raising the alarm on the hidden harm crisis in the treatment of leg and foot conditions. The Legs Matter Roadshow, Society of Tissue Viability Annual Report 11 August 2025 Section D Achievements and performance a national series of events aimed at podiatrists and community nurses, was launched and proved incredibly popular. • **SToP the Pressure** : working again in collaboration with the National Wound Care Strategy Programme and supported by media partners Mark Allen Group and Wounds UK, the focus for the 2024 campaign was on inclusion and asked the question ‘Are we really looking, are we really listening’. • **Wounds Research Network (WReN)** : WReN lead an evidencebased practice stream as part of the EWMA 24 conference in London, bringing together the UK's skin health and wound research community. • **Revised Seating Guidelines** : our Seating Guidelines were carefully revised in 2024 to provide a comprehensive, practical resource grounded in the latest research and evidence surrounding pressure ulcer prevention and management. • **International Wound Debridement best practice recommendations** : collaborative working with Nurses Specialized in Wound, Ostomy and Continence Canada (NSWOCC) produced a joint consensus document on best practice in relation to sharp debridement which was published open access in the JTV. • **Journal of Tissue Viability (JTV)** : the JTV transitioned to Gold Open Access during 2024 and its Impact Factor rose to 2.8, outperforming similar titles in its sector. • **Wider public engagement** : at the end of 2024 there were 5,014 people subscribed to receive our e-newsletter which consistently had open rates around 30% with our highest open rate for 2024 at 47.9% during Legs Matter week; the website attracted well in excess of quarter of a million page views, with almost 75,000 active users and regularly achieved over 1,000 page views a day. Credit and thanks must go to the Society’s dedicated Trustees and all those associated with our Council including PINK Marketing (Sue Simmonds, Kerry Wiles and Dawn Rush) and administrator Charlotte Hurdman, all of whom work consistently hard and passionately for the charity. Not forgetting our enthusiastic members, partners in industry and _Journal of Tissue Viability_ without whom the Society would not be what it is today. The Council of Trustees and Society of Tissue Viability is comprised of people united in their passion for wound care and skin health and their drive to help solve the challenges of wound care as part of a much wider collaborative approach. |**Section E**|**Financial review**| |---|---| |**Brief statement of the**
**charity’s policy on reserves**
**Details of any funds**
**materially in deficit**|| ||The Trustees are committed to maintaining financial reserves equivalent
to one year’s running costs.| ||The Society is not currently in deficit| Society of Tissue Viability Annual Report 12 August 2025 ## **Section F Other optional information** ## **Section G Declaration** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** |**Section G Declaration**|**Section G Declaration**|**Section G Declaration**| |---|---|---| |**The trustees declare that they have approved the trustees’ report above.**
**Signed** **on behalf of the charity’s trustees**||| |**Signature(s)**||| |**Full name(s)**|Sarah Gardner|| |**Position (e.g. Secretary,**
**Chair, etc.)**|Chair of the Council of Trustees|| |**Date**|07/09/2025|| Society of Tissue Viability Annual Report 13 August 2025 Charlty Number: 1180844 CHARITABLE INCORPORATED ORGANISAIION (CIO) TISSUE VIABILITY SOCIETY (TVS) WORKtNG NAME: SOCIETY OF TISSUE VtABILITY TRUSTEES, REPORT AND FINANCIAL STATEMENTS r4OR THE YEAR ENDID 31ST DECEMBER 2024 NORTIIOVER & COAccouMfANTS LTD eFIARTEIIII) ACCOUNTANTS 13ZA BOURNFJ¥fOUTII ROAD riiANDLERS FORP. SU53 JAL TISSUE VIABILITY SOCIETY (TVS) TABLE OF CONTENTS Page I Legal and Administs"ative Information Page 2 Independent Examinei s Report Page 3 Income and Expenditui'e Account Page 4 Comparative Income and Expenditure Account Page 5 Balance Sheet Pages 6 to 12 Notes to the Financial Statements Appendix I Report of the Trustees TISSUI, VIABILITY SOCIF.TY (TVS) LEGAL ATr4D ADMJNISTRATIVL JNFORMA'fioN Ti$￿}e Viability Society ].% 8n unincorporatcd elltity and a rcgistcrcd charity goveTncd by its niemoralldulli and articles of association. The eharity adoptcd a woi'kiiig naine of Society of .1 i5511e Viability. wliich was votcd iipon ai the 2021 AGM ai)d was foinially adopted by the charity iii I'ebiiiaiy 2022. The legal iianie of the cliarity remains unchanged al this time. CHARtTY NUMBER 1180844 DATE or RE4 CIST114TKON 20 fioveMJbei' 2018 TRUSTEES CHAIR SArah Cardnoi- VICE-CHAIR Sharon Ncill- from Sept 2024 ,leannie Donnelly- resigned Sept 2024 TREASURER David Hibbitt DEPUTY TREASURER Kate Williains OTHER TRUSTEES SrlniwAsa Buditlil Ina f4arr¢lly Madeleine Flana¥atL Clai'e Gyeenivood Natasha l.tvy- i'eslgned Sept 2024 Ayesha Marshall VlttoJ'l# Mui'j'ay FrHn NorTV#￿- i'eslgn¢d Sept 2024 SAmantlia Rooney Sliai'on StAttergood Contiie Trayiior- resigned Sept 2024 Petti. Wor$ley Sfiyah Bradbuiry- appo1￿10￿ Sept 2024 Julle H¢ivish- appointed Sept 2024 Inés P¢relra- 8ppolThted Sept 2024 Luxmi DhDonmoon- appointed Sept 2024 PRINCIPAL ADDRESS Cllllical Ti'lals Researeli Unlt UDlversity of Leed5 Letds LS2 9JT ACCOUNTANTS Noitthover & Co. Ac¢ountAnts I,td 132A Bournemouth RoAd Clixttdlers Fol-d Hampihlre S053 JAL BANKF,RS Lloyd5 Hliik Pl.C 120 Leis'151iam Hlgb Street LortdoiE SE13 6JC TISSUE VIABILITY SOL"IEI TY (TVS) INDLPLNDEN'f Li XAMINLI R'S REPOR'f TO THE TRUSTEES OF TISSUF. VIABII.ITY socifi.TY We repoil on Ilie ae¢ourtts of the compaiiy for Ilie yearended 3181 Decembet 2024 which are set out on pages 3 10 12. RESPECTIVE RESPONSIBILII'ILI S 01,. I'IIL'I'RUSTLI Ei S AND LI XAMINEI R The liusiees are respoiisible for the preparalitsn olihe aCC4)Un￿ an<1 Ilicy wnsider Iliat an audii is not Irquired f(Ii' tliis year Haviiig sAlisfied ourselves tlial IliechBTiry is llot subject to an audit Dlld is eligible for indepeiident exaiiiinalion, il is our respottsibiliry lo.. txainlne the atcoullts llnder sectlon 145 of Ihe 2011 Aet. folluw the pl.ocedu￿8 lald doivll lji the general Dli'ectlons kilvell by the Charlty Comnilsslon under 5ectioii 14515llhl of tlie 2011 Att. stAie ivhether pArllcular marreis IiAve corne to our Atteijdon. JIASIS OI., INDLI PENDEN'f Ei XAMINER'.S REPORT Our cxanunation was c41'1'ied Qui in llccoid8n¢¢ with the genci￿1 Diirctions given by the Charity Comn]iswon. A examiIiaiion irtcludes a iEview of Ilie a¢¢ouiiting records kepi by Ilie L'h21iiy aiid a colliparison gfElie accounts preqenied willi those teeoi'ds. It also includes ¢onbidtldiion orally iinusiial ii¢ins or di$¢liJsures In Ilie aicourtts, and seekiiiB expi3jlalioi￿ frojnyou as trustees coiicuning3ny siich Inatters. The pl￿ed11[c5 uiidcrlaktn do iiol provid¢ all Ilie ¢vid¢nc¢ thai would be required in an Audit, aiid cotTr%equenily no op1￿1&n 1.% given as lo wlietheT the accounts prcscnt a 'Irue and fairview. and th¢ rcport is liirited 10 those InaEters setout in the slalwn¢nt below. INDEPENDENT F,X4IMINLI RIS STATEMKNI, In coniieclioii with oui Cxal￿natIOJ1, no nThllci h35 coittc 10 our amertiion.. 11) which giires us Icasonablc cause lo belicvc thai, in any Inaierial rtwecl, Ihe requiiiin¢nls'. lo kery accounting sn a¢coTdance witb Se¢lion 386 of the coMk￿nieS Aci 2006., Iy to PlTpare accounts wliich &gree iviih Ihc acctrunlillg records and coiiiply iviih the accounting requiremen18 of section 396 of Ilie Companies act 2￿6 olld with the methods and principles of the Staiemeiil of Rt¢omn*nded Praciice.. Ac¢ouniing 2nd Reportin8 by Charilthes liav¢not ixen Inel. or 12) 10 wliicli, in our opinion, attention sliould be dixwjj in order lo enBble a pl￿per uiiderstandi118 of the accounts lo be IEadicd. h)orth￿￿ & Ctr f)c*e¢........ SePteffllTrer 2025................ NOR'I'HOVER & CO ACCOUNTANTS LIMII'ED CJIAR TlI.RF:I) AC.'COUNTANTS IJ2A BOURNEMOUTH ROAD CHANDLERS FORD, HAMPSHIRE S053 JAL TISSUE VIABILI'fY Socili TY (I'VS) S'l'A'fEMEI NT ofi Fi INANCIAL ACTIVITIFS FOR THE YEAR ENDED .IIST DECEMIIF,R 2024 SUMMARY INCOME AND EXPENDITURE ACCOUDIT Restricted Unrtstricted TOTAL FUNDS Notes Funds 2024 2023 INCOIVJING REI SOURCES In¢oining resources froni gelleixted funds Project incojne Subscriptions Dona¢ioi)s and legaties Jnvesiinent irt¢oii)e Other income 176,623 92,945 32,756 696 739 269,568 32,756 696 739 345.634 28.OJ5 1.072 287 TOTAL INCOMING RESOURCES 176.623 127,136 303,759 575.008 RESOURcf.s F.XPENDED Project expcnditurc Slrategylmis.%ion cxpcnditurc Charitable activitics 171,560 94,145 8,227 34,087 265,705 8,227 34,087 309,050 7,44(5 41, 774 TO'I'AL EXPENDITUR 171,560 136,459 308,019 T INCOMING RESOURCES -SURPLUSI(DEFICIT) FOR THE YEAR BEFORE TRANSFERS 5,063 {9J23) (4,260) (43.808) 'rransfers between funds NET INCOME/(DLFICIT) FOR'I'HE YEI AR 5,063 {9,323) (4,260) (43.fi68) Totsl fiind5 bTOLight fonvai'd 100,885 202,228 303,113 340,98] TOTAL FUNDS CARRIED FORWARD 105,948 192,905 298,853 303,J13 The Income and Expenditure Account incl￿deS all gains and losses i'ecognised in the y¢&r. All incoinc and expcnditui'e dei'ives fi'oin coi)tinuing activitics. TISSUF. VTABILITY SOCIF.TY (TV,8) STATLMF,NT OF FINANCIAL ACTIVITIES FOR I'HE YEAR ENDED 31SI' DEI CEMBLI R 2024 COMPARATIVE.SUMMARY INCOME AND EXPENDITURE ALCOUNT 2023 TOTAL Rcsti'ictcd UniEsts'icted I",UNI)S Notes FLinds Fund5 2023 INCOMIIS'G RESOURCES In¢uming resources fix>in gertEiaied funds Project iIicom %ubscriptlOllS onstions and legacies Investmenl income Otlier inLome 238,402 J07,232 28,015 1,072 287 345,634 28.015 1.072 287 (6) TOTAL INCOMING RFSOURCES 238,402 136,606 375,008 RESOURCES EXPENDED Projcct expendiliire StrategyliMi5sion expenditure ChariLqble activities 286,460 83,IPO 7,446 41, 774 36Q,656 7,446 41, 774 19) I'OTAL LXPEI NDII'URE 28tS,460 132.410 418,876 NET INCOMING RESOURCES FOR THE YEAR BEFORE I'RANSbLKS (48.058) 4.190 (43.868) Transfers between fiinds NFT INCOME/{DF.FJCJT) FOR THE YEAR (48,058) 4, 190 (43.808) Tolal funds broiigiit foiivard J46,943 198,038 346,961 TOTAL FUNDS CARRIED FORWARD 100.885 202,22 303, 113 TISSUF. VIABILITY SOCIETY (TV,%) STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31s'r DEI CEMBER 2024 BALANCE SI4EET AS AT 31ST DECEI MBER 2024 Notes 2024 2023 CURRENT ASSETS Debtors Cash at baIik and sn hand (12) 244,278 203,713 J48,556 J92,O69 447,991 340,625 CREDITORS: Amount% falling due within one year 149,138 37,512 149,138 37,512 NF,T CURRETr￿ ASSF.TS 298,853 303, 113 NET ASSETS 298,853 303,113 CAPIT AL Uni'estricted funds G¢n¢r21 thnd Restricted funds (14) 192,905 105,948 202,228 JOQ,885 298,853 303,113 The financial statements wei-e appi'oved by the board on and signed on ils behalf by: Sarah Gardner Chaii. 'flSSUE VIABILI'I'Y SOCILI I'Y (TVS) r+lC)'I'LI s'ro T'HE FINANCIAL STA'I'LI MLI N'I'S FOR I'HE YEAR ENDED 31ST DCCEMBER 2024 I ACCOUN'IINC I>OI.IC'IES 1.1 I JIAiis of prepAI'Ation of financi4l 5t8tcTh¢rtt$ Tli¢ finart¢ial $12temeiits have been pre1)a￿d iii a￿orda]Ice with Ilie CL￿rI11t$ SOHI) (FRS 1021- Accounting #nd R¢portittg by Chai-llics.. Slalcmeiil of Re¢oiniii¢nd¢d Pracliee applicable to chaiities PTcpai-ing Ilieira¢¢owiL% iii accoidallce willi Ihe FirJaDcial Rep￿tting Standard applicable in Ilie UK 2nd Republic of ￿e1&1]d IFRS 1021 leffecliv¢ l JaiiJary 20191, tlje Fiiiitscial Rei)01ling 81oDdard hpplicable in ilie UKand Rcpublic of Ircland IfRS 1021 and tlic Chaiiiies Act 2011. Tissue Viabiliiy Society meets the defillltion of 3 piiblic benefit ¢nlily und¢r fRS 102. Assets and liabilities orc initially recognised at liistorical cost oi"transa¢iion valut unlL%% odiuivi.* St￿ted in thcrclcvaiit accouniingpolicy. 1.12 Fund accounting Getier31 fuiids are UikneSlri¢ied fundx ivhich ale 2vailable foi. use al Ilie discicli(Jii Trf thc Tr￿tee5 in furihei?iice of the general (l)jeciives of tlieai81.ity and whicli havc llot li¢en dtSi8nalcd f(Ji' Othei'puiposes. Desi8iialed fiinds coinwise uiiresirictcd funds thai have heen set aside by Ihc'l iustccs foT P#rti¢ul8r purposes. The aiill and ua¢ of ¢a¢h dtsignated fvnd are set out IT) the notes to the finanth¥l s¢gten]ents. Restiieled fuiids are funds whi¢Ji a￿ 10 bt used in accordaiice ivilli specific ieslriclions lill￿5¢￿ by donots m. which liave bccn rai.%¢d by the Cliarity for psrticulai putPOSC5. Th¢¢osi8 of r4isinD oiid administering such funds are ¢h*rged against the st￿ClfiC fllnd. 1.13 IncoiJ]e All iiiconw is rccognis¢¢l once the C.hai'ity has enlitlemcnl to Ilie in¢ome, it is pl￿babIe Iliat tile income will be ieteived and the amount of i￿come receivAble can be measured reliably. Incomc tax iecoverable tn lylati(￿ to donatiolls Trteived (iitl Aid or de£d8 Ot'coveiiaDI is recognised al the tiTne ol'the donation. 1.14 Expenditut'e Expenditure ts recognised once itsere is a legal or consiruclive obbgaiioJ] to ttansfeie¢onoiJiic benefit to a Ibird wiy, it j5 probable tliat a transfei of eeoijomic benefits ivill br rcquired in $etilem•il and ihe amouiil of Ilie obligation ¢un bt meA8ured rdiably. Governance costs are those ill¢u￿ed in ¢onnection with adtniThislrdlioll of Ilie ch3rily 3nd coinpliaii¢¢ with consti￿110n8l aiid slalutory rcquirrAhe411S. Costs of gencyat￿￿ futtds are ¢08rs Inc￿rred in attjacliiig voluDlary income. and those incurred in Itadiijggctivities that taise futids. 1.1.s'rfittgible fixed assets rhc cost of thngibl¢ fixcd aqsets, if any, is expenthd ¢0 Ibe ID¢ome & Expenditure Account in the periods ofa¢quisition. Wd)sile dcsign costs. if any, #Te Wrill¢tt off in the year tiw are incuired. 1.16 Dcbtoi's Tr#d¢ and other debtor£ air re¢ogRised ai th¢ settl￿￿ent ainounl after any trade dixcouni otT¢red. Pttpa)rynents zie valued at t]K amount pj'epaid nei of any tiade dtscounts due. Casli at battk and in includes cAsh #rtd Sliort-ierni b)￿[Y liquid inveslillents with a short maturity ofiliree lnoni1￿ or ]ess rrom the date of a¢qui$ition oropeniiig of the deposil tr'similir ac¢¢uDI. I.JS Ci'¢ditoi's Creditors PTOVI8IO]18 are rccognised ivhaE the cluTiiy has a preseiit obliga11￿1 resulting frojn a past event thai ivill e51imaied rdiably. Creditors alld pl￿VisIO115 ai¢ noniially reeowiised at Ilicir settleinent amount aftet allowing for any tixde djscounts due. TISSUE VIABILITY SOCIETY (TVS) NOTES TO THF. fi INANCIAL STATEMENTS FOR THE YFAR EI NDEI D 31.ST DECEMBER 2024 I ACCOUNTING POLICIES (cont.) 1.19 Fill2J]tlal itistrumenls Tlje clydriiy lias decled lo apply Ihc iJrovisions of Seetian I I 'Basic financial bistrun*nis' of FIIS 102 10 all ofits fuianci81 iisiruinents. Fiiianci31 ins1ru￿￿n1* ar¢ LfW8niged in die clJ&ritys b&Janc¢ sheet wli¢n th¢ cliariry beooines party to thecontraeiual ovisions of Ilie inslNmeiil. Basic financ￿al assets, Ivhi¢li ￿¢[￿de debtors aijd baijk balatjces, ale lili1￿][Y Ixea8ured at traiisaciioji priee iiicludiiig Irartsaetioil Costs alld aresubsequeiiily cartied al al￿OrtiSed cosi USi118 the effective lill￿'c5t nieihod. fiiian¢ial assci% classified as I'eceivablc within on¢ y¢arait ii(st aiMoiti.%ed. Basic financial liabilities, including creditors, are inilially rcr(wi%cd ai Iransactioii ptice and air 5ubscqueiiily ¢airied ai aMart￿Sed cost usiiigthe cff¢clivc iiiitrttst Inelli￿1. Financial liabilit￿eS cI3ssified as payabl¢ wiihiii one year are llDt amorrised. 1.20 TAxAtion The cbarily is exempi from coiporaiion tsx Oll its cliarilablc aGlivitiGS. .21 Goijig coiicei. At the iiine of approviiig the financial slaiaiients aiid af￿r ¢otssideiingcuYrellt and ongoing Pmjecls and fiiiaTicial eommitimenls, Ilie Itustees h4Vt 4 rea%oJiable expectaiioll that the Chaiity has ad¢qual¢ r¢souire4 lo c￿lI1￿ue its operational 151rnct for Iht next 12 Inoiith i)eriod, a peiiod whi¢li ihey cojsidersufficient enough, lo be able 10 make sultahle sti?legic decisions concerniiig Ilie So¢le￿8 future, should ils finaiicial cir¢uinsthrtees unexpeetallily deierioiale orcliange. Tiius Ili¢ lioldin8 trustees coiiiinue lo adopt Ilit going toiicern basis of aCc￿li1111g iii preiiaring Ihc finan¢i¥l $￿ttin¢￿[s. 2 TRUSTEES, RESPON.SIBILITIE4 S IN RESPECT OF'I'HF. FINANCIAI. STATEMENTS Tli¢ law applicable to ch￿illeS in England aiid Wales requiiis the iyuslees to piepaTe fjnancial siaieihertts fur vach financial ead tsf Llie ye31'. prepating fiiian¢ial staiemei)14 ￿VIng a true and fattview, the Irusttts sliould fo51ow btst practice and.. •sele¢i suitsblc ￿Oll￿tillg wlicies atsj then apply Ihem consistelltly., "mske judgeinents And cslimates thai ar¢ re8sDn&ble ￿ld piudcRt' siale wlieilier 4)plicablt aeeouniingstandai￿s and slaleiiients nf r¢tommended practice have been followcd, 5ttbje¢i to any depaitures disclosed and cxplaincd in lh¢ fin811cial statemenis., i)rep3re the fllian¢ial stateinents on the going coiicern basis ulllc5% il 18 inapi?rowiate topiesuine thatthe &ocictyivill ¢oniiiiu¢ in opcialion. The trustees are responsible for keeping aecouniillg ￿cordS whicli disc1￿ with rtrdsonable accuracy Ilie financial position of IhÈ 51)tlety Èiid ivliich enable Iliein to asccitain th¢ finallcigj pngition of the society and wl3icli ¢iiable thon to ¢nsu¥e Iliat die ringncial statem¢iiis ¢omplywitli applic3ble law. They aTe also resp)nsible for safegusrdillg the assrfs of the so¢iety 2nd hejce for takiDg teAsonable steps fol. the preventioii and deleclion of ftaud *iid othtr iiYe8ulaiities. 3 RESERVES POLICY The ¢harily regulatioiis reqllii'e the society iodcfinc 118 poli¢y in re4)cct of reseives. T1￿ tiuslees consider Ihal as it Jio loiiger118s fllll tiJi)eeiiiployec5 with a pennanent basc. that it hold sufficient resetves to insure Ihgt it ¢an coniinue its attivitltt Ulisfaeiorily for a period of leasf 12 inonihs even ifits income was Si￿lif1Ca￿IIY educed. However thie Trustees do collsider Ilie Cliarily'.F onbtyirtg viability on ali 8nlluAI basis. Any fuiid5 and ongoing income Iiot Tequired for iiiimediai¢ netds 18 Put on deposit to Tnaximise inierestamd drawn upon 8S IT4uired. TISSUEI VIABILITY SOCIE'I'Y (TVS) NOTE,8 TO THE fil￿,ANcIAll, STATEMI ENTS FOR TIIE YEI AR NDLI D 31s'r DLCEMBER 2024 4 TOTAL PRoJEcf JNCOME & EXPENDITURE PROJF.L'r INCOME & If,XPlI NDI'I'URI, - UNRF.STRICTED 2024 Surplu (Deficit) 720 110,8761 14,926 4,225 111,4271 2023 38.293 37,57.1 10,876 21.474 3,275 20,947 660 (8,526) 34.817 8,108 682 3.52 Education PiY)gr&nJmc Faciliiaior c01por￿le Sponsors 40tt/. donalion elenierjl 2023124 EducJlional Eiidorseinuils Study Day% Webinar8 Speakei. fees WR¢N 36,400 7,500 9.520 1,232 1,232 (15,039) 92,945 94,145 {1,2O0) 24,036 PROJEC'f INCOME & F.XPEIlVDITURE- RESTRICTED Surplu51 (Dcficit) enrfilure Prior y￿r a¥Jjustments TVS conf￿liCe 2024 confer￿¢¢01gan7fCrCoSlS Legs Ma￿r Pjoject gkin Care Cli*iwioiJs Slep Ilie Pro%%uie 75,785 45,815 35,868 66,590 12,548 10,739 29,970 135.868) 20,198 (6,998) (2.239) 17.559 86,788 5,550 8,500 (19,760) 4,683 Jog 176,623 171,560 5,063 (48.058) TO'fAI, PROJECT INCOME & EXPENDITURE Sui'plusl Siiip1115/ Income tnditui'e 269,568 265.705 3,863 4,022) S TOT AI. PROJECT IIICOML & EXPF,NDITuRf (COMPARA'fivF. 2023) PROJECT INCOME & EI XPENDITURE- UNRESTRICTEI D {LOMPARATIVE) 2023 eJTdiiiii'e Joumals Educalion Pi-ograiiiinc Fa¢iliiati)I' CoTpoiilc Spon.Eor.4- 40D/. doiialion elen￿lt Edueaiional EndotEema)Is Study Days Wcbiiiars WReiN 53,485 32,819 8.52 61$ (8,520) 34,8J 7 8.108 $12 3.328 115,039) 34,8J7 11.500 20.43Q 7,000 3,392 19.74 3,672 15,fj39 107.232 83,19 24.030 TISSUTr. VIABILI'rY sociri TY rrvs) NO'I'ES 'I'O 'I'HL I,'INANLIAL S'I'A'I'LI MLN'I'S FOR THE YEAR LTrIDEI D 31S'I" DECEMBIR 2024 5 TOTAL PROJECT INCOME & EXPENDI'fuRE (COMI'ARATIVE 20231 ICONT.) PROJEC'f INCOME & EI XPENDITURL- RES'I'RicfED ICOIIqPAIiATIVE) 2023 Siirpliis1 (D¥fic'il) 54,554 (58,800) (06,4t53) 37,559 (J9, 760) Educational Giants 2023 EducDlional Giants 2022 TTansfei' Conf ITi¢oi#e fiom 2022 10 2023 -IVS CoiifciTncc Legs Matter Pl￿je¢t 54.554 (58.800) (66,465) 227.465 55,339 17.567 10,94 JK9,9QLf 72,899 I2,8￿4 JO,77J Slop Ilie Trt&¥UTe J6P 23&.4n2 286.460 (48,05¥ 1'0'fAI. IbROJTr.C'I' INCOME & EXPLNDI'I'URE {COMPAIUTIVE) 2023 345.fj34 3159,1f5Lf 124.022 6 DOIYA'fioNS AND LEC.ACIES 2024 2023 Donaiioras-J￿£I tiiviiig 696 J,072 7 INVESTMENT INCOME 2024 2023 Ittrcsi receivable 739 287 8 STRATEGYIIIISSION EXPENSES 2024 2Q23 EPUAP EWMA S¢holaiships D8n Badtr regeaich aivard Olho. coiifertne&% 1,2J9 406 J,130 4.499 1,000 6,008 j.éii 8,227 7,446 9 CHAIUTABLE £XPINDITURE- UNRESTRICTED 2024 2023 SUPPORT COSTS Markelijig, web5itc aiid iebTaiidixg ¢oyi$ Adininistralion assisian¢ Pi-IlllinR, posiay aiid ststioneiy Paypal Gliargt5 Sitipe ¢harges Bank ¢liai%e% Jusi GivIL￿ chaiEes 4,657 18,072 430 266 225 27 216 l.Q50 2,926 14,232 17,73J 125 27 J29 210 1.2R 2,80Q 228 Mecting cxiiensc5 Sundiy expeiises Can'ied forward 27.869 TISSUE VLIBILITY SOCRLI'Y (TVS) NOTEI S TO THE FINANCIAL STATEME4 NTS OR'fHE YEAR ENDF.D 31ST DECEMBER 2024 io. g CHARITABLI EXPENDITURF.- UNRESTRICTED IcoiYr,I 2024 2023 GOVERNANCE COSTS Indq)riidefti exAilliMlil)n ]ndep￿iden¢ exaiiiifkiiion- PllOTye4r 4,1100 1,418 4,74U 6,218 4.740 TOTAL CHARITABLE EXPEiN'DITURE 34,087 41.774 IO STAFF COSTS Th¢ average nuiiibeT of staff wployed during the year was O {2023., 0). Th￿t were no einployees whose alliiual remuneration was £60,000 or mole. 11 TRUSTLf.s ii¥.MUNfi.RATIOIY ANJ) EXPF.NSF.S During thc yeaT, amoullls wcre paidlreimiuT5cd lo th¢ ITUStees of the ch&Tity as follow&'. 2024 2023 Spe&kerfees rAueaiioiiAI pl￿gramIne Facilitsior Trnvel expenses 1,638 JO,876 700 8.810 2,132 lJ.642 Spcaker fccs wex paid 10 2 Trustett12023., 3) ftsT prepaTaiion alld $pe&king &t $ociety Study DAYS. Education ¢ndorseiii¢nl fees iver¢ paid lo O T￿Ste¢SI2023.. 0) for i'¢view work underlakell on educ31ional tnaterials as paTI of the Educational Endthsemerti offuiii Education Prograrnmc FatiliEatOT fecs ivtre ￿ld to l Tnjsiee for tA)nsultaiicy work on the or8aiiis&iion of 8iudy days aod other oi¥anisati￿7al work rcgarding Ilie aiinual conferences alld other charity S•W)¢es. Except 8s liS￿d above, no otlier reiiillnerglioll oi. expenses were paid loany Trustee during ihe year. 12 DEBTORS 2024 2025 Trgde debtors Amrtuiits due fi'nm Piiik@l>ink TVS Lld Prepa)menis and acti'ued ittconie 36,293 205,085 900 33.485 poo 244,278 148.556 13 CREDITORS.. AI%qOUNTS FALLING DUE WITHIN ONC YEAR 2024 Tthdc¢redili)TS Conference 2025- Iiel I'eceivable5 Corp(M?ie Partnership 2024-2025 A¢cruals al￿ defer￿J intome 1,515 101,719 L.53L J.513 35.999 149 138 57.512 TISSUE VIABILITY SOCIE'fY {TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEildBER 2024 ii. 14 UNRE,8'1'RICI'fD fiJNDS BIFivd lJJeDme oiidlture Tyaiisfej CIFwd Gaie¥al ful￿S 202,228 127,136 1136,459) 192,905 202,22 127 136 136 459 192905 IS RTr"tsTRWCTf,D fuND B/Fwd In¢ome ndlithi't Tr411$(ers Clwwd Educati￿1￿1 Gi'ants ree'd 2024 TVS Coiifei'ence 2024 Legs MRtter Skin Care Challipions STOP Ilie Pr¢ssur¢ 54,554 9,534 40,981 (2,353) {1.83J) 54,554 3,636 01,179 {9,.151) {4,070) 75,785 86,788 5,550 8,501b (81,683) {66,590) (12,548) (10,739) 100.885 176,623 {171.56111 105,948 Edu¢ationAI Gra￿19 The chaiiryreceives SPODSOtsbip thi'ough direct sponsorship or Ihiough ouriiered colp￿￿te inembeTship system 10 PTovide uyiits to liealihcare pmfts%ionals to eiiable tliein to all￿1d theTVS conferences Ènd exhibitiotis. The liealllicaie pi'ofesqionals ay Teceive a grant to cover Iravcl alld accomtnodation costs foT Ihe evcnl, a5 w¢ll a5 cov¢ring Ili¢ Cost of attcnding ihc events. TVS Coiiference Tlie cliaiity liolds an annu31 ¢onferen¢e eoveriiig a wide ra￿8¢of topi¢$ Iviihin the ieniii of the ¢barity ioenlaan¢e the k#owlcdBe aiid a¥varen&%£ nf tbesc taiiics f(x' liealtiicatr professional% across the eounliy. The ch&iityreLeivo% si%)nsorship and ?iilS 10 enable Ihis ¢onferen¢e 10 be held. Legs Maller Legs Matlyr is o coaliliort of orKanisaiioiis woikiiig togeiherro increase awareness. widerstandiixg and action on lower le8 aiid fool condilioiis aiiioiig Ilie public aiid liealihcare professioiials Ilirough year-¥ound activities and coininunicalions. Tlie chasily ieceives coipoi?le spoiisorsliip lo fund Iliis activity. Skiii C#re CliginpiDm$ Skin Cair Cliampions piovid¢5 p¢ople wotkiiig in ¢aiY li01n￿ and lioix¢ ¢are 48¢n¢ie8 a iJJsi¢d pro8r8mm¢ of ¢osi-¢ffe¢iive and easily accessibk education lo support skin health And ivound liealing. SiOP the Pi'¢ssure Slop'l'hc ljressurc aiins create & 8igntficant culture sliift aiid eliminatc avoidablc pressure ulcer% iii acul4 cominunity and mental liediih provider s¢rtin¥s Ilimugh 4 varieiy Or￿11VIlle9 to supJM)ri healiheare piYTrfessioiial. i]￿l￿dif18 Iiosting free wcbiiiars witli expeii s￿k￿3 leadiiig iiiforiiialive sessions. putting together training sessions foroiBanisalioiis and d￿r[OpIng 8raphi¢s and post￿3 wlii¢h b¢ adAPted lo¢ally 16 RELATED PARTIES Pink@Pink I"VS is a com￿nY r¢gi5tered in England gnd Wales Icoinpany Numkr.. 081998011 ivhich aets on bdialf o Tissue Viability Socieiy in Ilie oigalll$81ion aiid Inattagemeni of sevei?l of Ihe charity's fuods aitd eveilLS. ￿le ¢oihpary is cuiIEnlly owiied aiid iwnaged l)y illdividual% whojn 31e ijol Iiuslees of Ilie chaiity. The cliarity maintains OY￿sight Ot'lhe finaii¢ial dt41ings of Ili¢ ¢onipany Ihrough regular iiiaDagement rLyoning by the conipany tothc Ch￿￿ty. Listed bdoiv is an overall su]nmaiyof Ilic thi￿SactionS wlii¢li have beeD und¢rtaken on behalf of the Cliarity. 2024 In￿me 5%￿ndIture 36J,U48 270,132 90,916 370.056 425,302 (55.240 £J14,Y71 Al￿￿￿1l19 dDt fyom PliikOPlnk TVS Ltd_ Dlsclosed ivllliln Deblors TI,SSUE VIABII,ITY SOClb,'rY {TVS) NOTES TO THE FINANCIAI, SI'A'rr.Mfi NTS FOR THII YEAR F.NDED 31ST DFCTr.MIIF.R 2024 12. 17 ANALYSIS OF NET ASSLTS BETWEEN FUNDS Unresli-ictLd RestL'iCted 2024 As at 31 Decembei. 2024 Debtors Ilank and Casli Creditoi's 39,193 203,711 (45,888) {103,250 205,085 244,2711 203,713 (149,138) 197,018 101,835 298,853 Uni"¢sts'icted Resti'ictcd 2023 As at 31 December 2023 Debtors Bank and Cash Ciedilors 34,385 192,069 37,512 114,171 148,556 192,069 (37,512 188,942 114,171 303,113 Charlty Number: 1180844 CHARITABLE INCORPORATED ORGANISAIION (CIO) TISSUE VIABILITY SOCIETY (TVS) WORKtNG NAME: SOCIETY OF TISSUE VtABILITY TRUSTEES, REPORT AND FINANCIAL STATEMENTS r4OR THE YEAR ENDID 31ST DECEMBER 2024 NORTIIOVER & COAccouMfANTS LTD eFIARTEIIII) ACCOUNTANTS 13ZA BOURNFJ¥fOUTII ROAD riiANDLERS FORP. SU53 JAL TISSUE VIABILITY SOCIETY (TVS) TABLE OF CONTENTS Page I Legal and Administs"ative Information Page 2 Independent Examinei s Report Page 3 Income and Expenditui'e Account Page 4 Comparative Income and Expenditure Account Page 5 Balance Sheet Pages 6 to 12 Notes to the Financial Statements Appendix I Report of the Trustees TISSUI, VIABILITY SOCIF.TY (TVS) LEGAL ATr4D ADMJNISTRATIVL JNFORMA'fioN Ti$￿}e Viability Society ].% 8n unincorporatcd elltity and a rcgistcrcd charity goveTncd by its niemoralldulli and articles of association. The eharity adoptcd a woi'kiiig naine of Society of .1 i5511e Viability. wliich was votcd iipon ai the 2021 AGM ai)d was foinially adopted by the charity iii I'ebiiiaiy 2022. The legal iianie of the cliarity remains unchanged al this time. CHARtTY NUMBER 1180844 DATE or RE4 CIST114TKON 20 fioveMJbei' 2018 TRUSTEES CHAIR SArah Cardnoi- VICE-CHAIR Sharon Ncill- from Sept 2024 ,leannie Donnelly- resigned Sept 2024 TREASURER David Hibbitt DEPUTY TREASURER Kate Williains OTHER TRUSTEES SrlniwAsa Buditlil Ina f4arr¢lly Madeleine Flana¥atL Clai'e Gyeenivood Natasha l.tvy- i'eslgned Sept 2024 Ayesha Marshall VlttoJ'l# Mui'j'ay FrHn NorTV#￿- i'eslgn¢d Sept 2024 SAmantlia Rooney Sliai'on StAttergood Contiie Trayiior- resigned Sept 2024 Petti. Wor$ley Sfiyah Bradbuiry- appo1￿10￿ Sept 2024 Julle H¢ivish- appointed Sept 2024 Inés P¢relra- 8ppolThted Sept 2024 Luxmi DhDonmoon- appointed Sept 2024 PRINCIPAL ADDRESS Cllllical Ti'lals Researeli Unlt UDlversity of Leed5 Letds LS2 9JT ACCOUNTANTS Noitthover & Co. Ac¢ountAnts I,td 132A Bournemouth RoAd Clixttdlers Fol-d Hampihlre S053 JAL BANKF,RS Lloyd5 Hliik Pl.C 120 Leis'151iam Hlgb Street LortdoiE SE13 6JC TISSUE VIABILITY SOL"IEI TY (TVS) INDLPLNDEN'f Li XAMINLI R'S REPOR'f TO THE TRUSTEES OF TISSUF. VIABII.ITY socifi.TY We repoil on Ilie ae¢ourtts of the compaiiy for Ilie yearended 3181 Decembet 2024 which are set out on pages 3 10 12. RESPECTIVE RESPONSIBILII'ILI S 01,. I'IIL'I'RUSTLI Ei S AND LI XAMINEI R The liusiees are respoiisible for the preparalitsn olihe aCC4)Un￿ an<1 Ilicy wnsider Iliat an audii is not Irquired f(Ii' tliis year Haviiig sAlisfied ourselves tlial IliechBTiry is llot subject to an audit Dlld is eligible for indepeiident exaiiiinalion, il is our respottsibiliry lo.. txainlne the atcoullts llnder sectlon 145 of Ihe 2011 Aet. folluw the pl.ocedu￿8 lald doivll lji the general Dli'ectlons kilvell by the Charlty Comnilsslon under 5ectioii 14515llhl of tlie 2011 Att. stAie ivhether pArllcular marreis IiAve corne to our Atteijdon. JIASIS OI., INDLI PENDEN'f Ei XAMINER'.S REPORT Our cxanunation was c41'1'ied Qui in llccoid8n¢¢ with the genci￿1 Diirctions given by the Charity Comn]iswon. A examiIiaiion irtcludes a iEview of Ilie a¢¢ouiiting records kepi by Ilie L'h21iiy aiid a colliparison gfElie accounts preqenied willi those teeoi'ds. It also includes ¢onbidtldiion orally iinusiial ii¢ins or di$¢liJsures In Ilie aicourtts, and seekiiiB expi3jlalioi￿ frojnyou as trustees coiicuning3ny siich Inatters. The pl￿ed11[c5 uiidcrlaktn do iiol provid¢ all Ilie ¢vid¢nc¢ thai would be required in an Audit, aiid cotTr%equenily no op1￿1&n 1.% given as lo wlietheT the accounts prcscnt a 'Irue and fairview. and th¢ rcport is liirited 10 those InaEters setout in the slalwn¢nt below. INDEPENDENT F,X4IMINLI RIS STATEMKNI, In coniieclioii with oui Cxal￿natIOJ1, no nThllci h35 coittc 10 our amertiion.. 11) which giires us Icasonablc cause lo belicvc thai, in any Inaierial rtwecl, Ihe requiiiin¢nls'. lo kery accounting sn a¢coTdance witb Se¢lion 386 of the coMk￿nieS Aci 2006., Iy to PlTpare accounts wliich &gree iviih Ihc acctrunlillg records and coiiiply iviih the accounting requiremen18 of section 396 of Ilie Companies act 2￿6 olld with the methods and principles of the Staiemeiil of Rt¢omn*nded Praciice.. Ac¢ouniing 2nd Reportin8 by Charilthes liav¢not ixen Inel. or 12) 10 wliicli, in our opinion, attention sliould be dixwjj in order lo enBble a pl￿per uiiderstandi118 of the accounts lo be IEadicd. h)orth￿￿ & Ctr f)c*e¢........ SePteffllTrer 2025................ NOR'I'HOVER & CO ACCOUNTANTS LIMII'ED CJIAR TlI.RF:I) AC.'COUNTANTS IJ2A BOURNEMOUTH ROAD CHANDLERS FORD, HAMPSHIRE S053 JAL TISSUE VIABILI'fY Socili TY (I'VS) S'l'A'fEMEI NT ofi Fi INANCIAL ACTIVITIFS FOR THE YEAR ENDED .IIST DECEMIIF,R 2024 SUMMARY INCOME AND EXPENDITURE ACCOUDIT Restricted Unrtstricted TOTAL FUNDS Notes Funds 2024 2023 INCOIVJING REI SOURCES In¢oining resources froni gelleixted funds Project incojne Subscriptions Dona¢ioi)s and legaties Jnvesiinent irt¢oii)e Other income 176,623 92,945 32,756 696 739 269,568 32,756 696 739 345.634 28.OJ5 1.072 287 TOTAL INCOMING RESOURCES 176.623 127,136 303,759 575.008 RESOURcf.s F.XPENDED Project expcnditurc Slrategylmis.%ion cxpcnditurc Charitable activitics 171,560 94,145 8,227 34,087 265,705 8,227 34,087 309,050 7,44(5 41, 774 TO'I'AL EXPENDITUR 171,560 136,459 308,019 T INCOMING RESOURCES -SURPLUSI(DEFICIT) FOR THE YEAR BEFORE TRANSFERS 5,063 {9J23) (4,260) (43.808) 'rransfers between funds NET INCOME/(DLFICIT) FOR'I'HE YEI AR 5,063 {9,323) (4,260) (43.fi68) Totsl fiind5 bTOLight fonvai'd 100,885 202,228 303,113 340,98] TOTAL FUNDS CARRIED FORWARD 105,948 192,905 298,853 303,J13 The Income and Expenditure Account incl￿deS all gains and losses i'ecognised in the y¢&r. All incoinc and expcnditui'e dei'ives fi'oin coi)tinuing activitics. TISSUF. VTABILITY SOCIF.TY (TV,8) STATLMF,NT OF FINANCIAL ACTIVITIES FOR I'HE YEAR ENDED 31SI' DEI CEMBLI R 2024 COMPARATIVE.SUMMARY INCOME AND EXPENDITURE ALCOUNT 2023 TOTAL Rcsti'ictcd UniEsts'icted I",UNI)S Notes FLinds Fund5 2023 INCOMIIS'G RESOURCES In¢uming resources fix>in gertEiaied funds Project iIicom %ubscriptlOllS onstions and legacies Investmenl income Otlier inLome 238,402 J07,232 28,015 1,072 287 345,634 28.015 1.072 287 (6) TOTAL INCOMING RFSOURCES 238,402 136,606 375,008 RESOURCES EXPENDED Projcct expendiliire StrategyliMi5sion expenditure ChariLqble activities 286,460 83,IPO 7,446 41, 774 36Q,656 7,446 41, 774 19) I'OTAL LXPEI NDII'URE 28tS,460 132.410 418,876 NET INCOMING RESOURCES FOR THE YEAR BEFORE I'RANSbLKS (48.058) 4.190 (43.868) Transfers between fiinds NFT INCOME/{DF.FJCJT) FOR THE YEAR (48,058) 4, 190 (43.808) Tolal funds broiigiit foiivard J46,943 198,038 346,961 TOTAL FUNDS CARRIED FORWARD 100.885 202,22 303, 113 TISSUF. VIABILITY SOCIETY (TV,%) STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31s'r DEI CEMBER 2024 BALANCE SI4EET AS AT 31ST DECEI MBER 2024 Notes 2024 2023 CURRENT ASSETS Debtors Cash at baIik and sn hand (12) 244,278 203,713 J48,556 J92,O69 447,991 340,625 CREDITORS: Amount% falling due within one year 149,138 37,512 149,138 37,512 NF,T CURRETr￿ ASSF.TS 298,853 303, 113 NET ASSETS 298,853 303,113 CAPIT AL Uni'estricted funds G¢n¢r21 thnd Restricted funds (14) 192,905 105,948 202,228 JOQ,885 298,853 303,113 The financial statements wei-e appi'oved by the board on and signed on ils behalf by: Sarah Gardner Chaii. 'flSSUE VIABILI'I'Y SOCILI I'Y (TVS) r+lC)'I'LI s'ro T'HE FINANCIAL STA'I'LI MLI N'I'S FOR I'HE YEAR ENDED 31ST DCCEMBER 2024 I ACCOUN'IINC I>OI.IC'IES 1.1 I JIAiis of prepAI'Ation of financi4l 5t8tcTh¢rtt$ Tli¢ finart¢ial $12temeiits have been pre1)a￿d iii a￿orda]Ice with Ilie CL￿rI11t$ SOHI) (FRS 1021- Accounting #nd R¢portittg by Chai-llics.. Slalcmeiil of Re¢oiniii¢nd¢d Pracliee applicable to chaiities PTcpai-ing Ilieira¢¢owiL% iii accoidallce willi Ihe FirJaDcial Rep￿tting Standard applicable in Ilie UK 2nd Republic of ￿e1&1]d IFRS 1021 leffecliv¢ l JaiiJary 20191, tlje Fiiiitscial Rei)01ling 81oDdard hpplicable in ilie UKand Rcpublic of Ircland IfRS 1021 and tlic Chaiiiies Act 2011. Tissue Viabiliiy Society meets the defillltion of 3 piiblic benefit ¢nlily und¢r fRS 102. Assets and liabilities orc initially recognised at liistorical cost oi"transa¢iion valut unlL%% odiuivi.* St￿ted in thcrclcvaiit accouniingpolicy. 1.12 Fund accounting Getier31 fuiids are UikneSlri¢ied fundx ivhich ale 2vailable foi. use al Ilie discicli(Jii Trf thc Tr￿tee5 in furihei?iice of the general (l)jeciives of tlieai81.ity and whicli havc llot li¢en dtSi8nalcd f(Ji' Othei'puiposes. Desi8iialed fiinds coinwise uiiresirictcd funds thai have heen set aside by Ihc'l iustccs foT P#rti¢ul8r purposes. The aiill and ua¢ of ¢a¢h dtsignated fvnd are set out IT) the notes to the finanth¥l s¢gten]ents. Restiieled fuiids are funds whi¢Ji a￿ 10 bt used in accordaiice ivilli specific ieslriclions lill￿5¢￿ by donots m. which liave bccn rai.%¢d by the Cliarity for psrticulai putPOSC5. Th¢¢osi8 of r4isinD oiid administering such funds are ¢h*rged against the st￿ClfiC fllnd. 1.13 IncoiJ]e All iiiconw is rccognis¢¢l once the C.hai'ity has enlitlemcnl to Ilie in¢ome, it is pl￿babIe Iliat tile income will be ieteived and the amount of i￿come receivAble can be measured reliably. Incomc tax iecoverable tn lylati(￿ to donatiolls Trteived (iitl Aid or de£d8 Ot'coveiiaDI is recognised al the tiTne ol'the donation. 1.14 Expenditut'e Expenditure ts recognised once itsere is a legal or consiruclive obbgaiioJ] to ttansfeie¢onoiJiic benefit to a Ibird wiy, it j5 probable tliat a transfei of eeoijomic benefits ivill br rcquired in $etilem•il and ihe amouiil of Ilie obligation ¢un bt meA8ured rdiably. Governance costs are those ill¢u￿ed in ¢onnection with adtniThislrdlioll of Ilie ch3rily 3nd coinpliaii¢¢ with consti￿110n8l aiid slalutory rcquirrAhe411S. Costs of gencyat￿￿ futtds are ¢08rs Inc￿rred in attjacliiig voluDlary income. and those incurred in Itadiijggctivities that taise futids. 1.1.s'rfittgible fixed assets rhc cost of thngibl¢ fixcd aqsets, if any, is expenthd ¢0 Ibe ID¢ome & Expenditure Account in the periods ofa¢quisition. Wd)sile dcsign costs. if any, #Te Wrill¢tt off in the year tiw are incuired. 1.16 Dcbtoi's Tr#d¢ and other debtor£ air re¢ogRised ai th¢ settl￿￿ent ainounl after any trade dixcouni otT¢red. Pttpa)rynents zie valued at t]K amount pj'epaid nei of any tiade dtscounts due. Casli at battk and in includes cAsh #rtd Sliort-ierni b)￿[Y liquid inveslillents with a short maturity ofiliree lnoni1￿ or ]ess rrom the date of a¢qui$ition oropeniiig of the deposil tr'similir ac¢¢uDI. I.JS Ci'¢ditoi's Creditors PTOVI8IO]18 are rccognised ivhaE the cluTiiy has a preseiit obliga11￿1 resulting frojn a past event thai ivill e51imaied rdiably. Creditors alld pl￿VisIO115 ai¢ noniially reeowiised at Ilicir settleinent amount aftet allowing for any tixde djscounts due. TISSUE VIABILITY SOCIETY (TVS) NOTES TO THF. fi INANCIAL STATEMENTS FOR THE YFAR EI NDEI D 31.ST DECEMBER 2024 I ACCOUNTING POLICIES (cont.) 1.19 Fill2J]tlal itistrumenls Tlje clydriiy lias decled lo apply Ihc iJrovisions of Seetian I I 'Basic financial bistrun*nis' of FIIS 102 10 all ofits fuianci81 iisiruinents. Fiiianci31 ins1ru￿￿n1* ar¢ LfW8niged in die clJ&ritys b&Janc¢ sheet wli¢n th¢ cliariry beooines party to thecontraeiual ovisions of Ilie inslNmeiil. Basic financ￿al assets, Ivhi¢li ￿¢[￿de debtors aijd baijk balatjces, ale lili1￿][Y Ixea8ured at traiisaciioji priee iiicludiiig Irartsaetioil Costs alld aresubsequeiiily cartied al al￿OrtiSed cosi USi118 the effective lill￿'c5t nieihod. fiiian¢ial assci% classified as I'eceivablc within on¢ y¢arait ii(st aiMoiti.%ed. Basic financial liabilities, including creditors, are inilially rcr(wi%cd ai Iransactioii ptice and air 5ubscqueiiily ¢airied ai aMart￿Sed cost usiiigthe cff¢clivc iiiitrttst Inelli￿1. Financial liabilit￿eS cI3ssified as payabl¢ wiihiii one year are llDt amorrised. 1.20 TAxAtion The cbarily is exempi from coiporaiion tsx Oll its cliarilablc aGlivitiGS. .21 Goijig coiicei. At the iiine of approviiig the financial slaiaiients aiid af￿r ¢otssideiingcuYrellt and ongoing Pmjecls and fiiiaTicial eommitimenls, Ilie Itustees h4Vt 4 rea%oJiable expectaiioll that the Chaiity has ad¢qual¢ r¢souire4 lo c￿lI1￿ue its operational 151rnct for Iht next 12 Inoiith i)eriod, a peiiod whi¢li ihey cojsidersufficient enough, lo be able 10 make sultahle sti?legic decisions concerniiig Ilie So¢le￿8 future, should ils finaiicial cir¢uinsthrtees unexpeetallily deierioiale orcliange. Tiius Ili¢ lioldin8 trustees coiiiinue lo adopt Ilit going toiicern basis of aCc￿li1111g iii preiiaring Ihc finan¢i¥l $￿ttin¢￿[s. 2 TRUSTEES, RESPON.SIBILITIE4 S IN RESPECT OF'I'HF. FINANCIAI. STATEMENTS Tli¢ law applicable to ch￿illeS in England aiid Wales requiiis the iyuslees to piepaTe fjnancial siaieihertts fur vach financial ead tsf Llie ye31'. prepating fiiian¢ial staiemei)14 ￿VIng a true and fattview, the Irusttts sliould fo51ow btst practice and.. •sele¢i suitsblc ￿Oll￿tillg wlicies atsj then apply Ihem consistelltly., "mske judgeinents And cslimates thai ar¢ re8sDn&ble ￿ld piudcRt' siale wlieilier 4)plicablt aeeouniingstandai￿s and slaleiiients nf r¢tommended practice have been followcd, 5ttbje¢i to any depaitures disclosed and cxplaincd in lh¢ fin811cial statemenis., i)rep3re the fllian¢ial stateinents on the going coiicern basis ulllc5% il 18 inapi?rowiate topiesuine thatthe &ocictyivill ¢oniiiiu¢ in opcialion. The trustees are responsible for keeping aecouniillg ￿cordS whicli disc1￿ with rtrdsonable accuracy Ilie financial position of IhÈ 51)tlety Èiid ivliich enable Iliein to asccitain th¢ finallcigj pngition of the society and wl3icli ¢iiable thon to ¢nsu¥e Iliat die ringncial statem¢iiis ¢omplywitli applic3ble law. They aTe also resp)nsible for safegusrdillg the assrfs of the so¢iety 2nd hejce for takiDg teAsonable steps fol. the preventioii and deleclion of ftaud *iid othtr iiYe8ulaiities. 3 RESERVES POLICY The ¢harily regulatioiis reqllii'e the society iodcfinc 118 poli¢y in re4)cct of reseives. T1￿ tiuslees consider Ihal as it Jio loiiger118s fllll tiJi)eeiiiployec5 with a pennanent basc. that it hold sufficient resetves to insure Ihgt it ¢an coniinue its attivitltt Ulisfaeiorily for a period of leasf 12 inonihs even ifits income was Si￿lif1Ca￿IIY educed. However thie Trustees do collsider Ilie Cliarily'.F onbtyirtg viability on ali 8nlluAI basis. Any fuiid5 and ongoing income Iiot Tequired for iiiimediai¢ netds 18 Put on deposit to Tnaximise inierestamd drawn upon 8S IT4uired. TISSUEI VIABILITY SOCIE'I'Y (TVS) NOTE,8 TO THE fil￿,ANcIAll, STATEMI ENTS FOR TIIE YEI AR NDLI D 31s'r DLCEMBER 2024 4 TOTAL PRoJEcf JNCOME & EXPENDITURE PROJF.L'r INCOME & If,XPlI NDI'I'URI, - UNRF.STRICTED 2024 Surplu (Deficit) 720 110,8761 14,926 4,225 111,4271 2023 38.293 37,57.1 10,876 21.474 3,275 20,947 660 (8,526) 34.817 8,108 682 3.52 Education PiY)gr&nJmc Faciliiaior c01por￿le Sponsors 40tt/. donalion elenierjl 2023124 EducJlional Eiidorseinuils Study Day% Webinar8 Speakei. fees WR¢N 36,400 7,500 9.520 1,232 1,232 (15,039) 92,945 94,145 {1,2O0) 24,036 PROJEC'f INCOME & F.XPEIlVDITURE- RESTRICTED Surplu51 (Dcficit) enrfilure Prior y￿r a¥Jjustments TVS conf￿liCe 2024 confer￿¢¢01gan7fCrCoSlS Legs Ma￿r Pjoject gkin Care Cli*iwioiJs Slep Ilie Pro%%uie 75,785 45,815 35,868 66,590 12,548 10,739 29,970 135.868) 20,198 (6,998) (2.239) 17.559 86,788 5,550 8,500 (19,760) 4,683 Jog 176,623 171,560 5,063 (48.058) TO'fAI, PROJECT INCOME & EXPENDITURE Sui'plusl Siiip1115/ Income tnditui'e 269,568 265.705 3,863 4,022) S TOT AI. PROJECT IIICOML & EXPF,NDITuRf (COMPARA'fivF. 2023) PROJECT INCOME & EI XPENDITURE- UNRESTRICTEI D {LOMPARATIVE) 2023 eJTdiiiii'e Joumals Educalion Pi-ograiiiinc Fa¢iliiati)I' CoTpoiilc Spon.Eor.4- 40D/. doiialion elen￿lt Edueaiional EndotEema)Is Study Days Wcbiiiars WReiN 53,485 32,819 8.52 61$ (8,520) 34,8J 7 8.108 $12 3.328 115,039) 34,8J7 11.500 20.43Q 7,000 3,392 19.74 3,672 15,fj39 107.232 83,19 24.030 TISSUTr. VIABILI'rY sociri TY rrvs) NO'I'ES 'I'O 'I'HL I,'INANLIAL S'I'A'I'LI MLN'I'S FOR THE YEAR LTrIDEI D 31S'I" DECEMBIR 2024 5 TOTAL PROJECT INCOME & EXPENDI'fuRE (COMI'ARATIVE 20231 ICONT.) PROJEC'f INCOME & EI XPENDITURL- RES'I'RicfED ICOIIqPAIiATIVE) 2023 Siirpliis1 (D¥fic'il) 54,554 (58,800) (06,4t53) 37,559 (J9, 760) Educational Giants 2023 EducDlional Giants 2022 TTansfei' Conf ITi¢oi#e fiom 2022 10 2023 -IVS CoiifciTncc Legs Matter Pl￿je¢t 54.554 (58.800) (66,465) 227.465 55,339 17.567 10,94 JK9,9QLf 72,899 I2,8￿4 JO,77J Slop Ilie Trt&¥UTe J6P 23&.4n2 286.460 (48,05¥ 1'0'fAI. IbROJTr.C'I' INCOME & EXPLNDI'I'URE {COMPAIUTIVE) 2023 345.fj34 3159,1f5Lf 124.022 6 DOIYA'fioNS AND LEC.ACIES 2024 2023 Donaiioras-J￿£I tiiviiig 696 J,072 7 INVESTMENT INCOME 2024 2023 Ittrcsi receivable 739 287 8 STRATEGYIIIISSION EXPENSES 2024 2Q23 EPUAP EWMA S¢holaiships D8n Badtr regeaich aivard Olho. coiifertne&% 1,2J9 406 J,130 4.499 1,000 6,008 j.éii 8,227 7,446 9 CHAIUTABLE £XPINDITURE- UNRESTRICTED 2024 2023 SUPPORT COSTS Markelijig, web5itc aiid iebTaiidixg ¢oyi$ Adininistralion assisian¢ Pi-IlllinR, posiay aiid ststioneiy Paypal Gliargt5 Sitipe ¢harges Bank ¢liai%e% Jusi GivIL￿ chaiEes 4,657 18,072 430 266 225 27 216 l.Q50 2,926 14,232 17,73J 125 27 J29 210 1.2R 2,80Q 228 Mecting cxiiensc5 Sundiy expeiises Can'ied forward 27.869 TISSUE VLIBILITY SOCRLI'Y (TVS) NOTEI S TO THE FINANCIAL STATEME4 NTS OR'fHE YEAR ENDF.D 31ST DECEMBER 2024 io. g CHARITABLI EXPENDITURF.- UNRESTRICTED IcoiYr,I 2024 2023 GOVERNANCE COSTS Indq)riidefti exAilliMlil)n ]ndep￿iden¢ exaiiiifkiiion- PllOTye4r 4,1100 1,418 4,74U 6,218 4.740 TOTAL CHARITABLE EXPEiN'DITURE 34,087 41.774 IO STAFF COSTS Th¢ average nuiiibeT of staff wployed during the year was O {2023., 0). Th￿t were no einployees whose alliiual remuneration was £60,000 or mole. 11 TRUSTLf.s ii¥.MUNfi.RATIOIY ANJ) EXPF.NSF.S During thc yeaT, amoullls wcre paidlreimiuT5cd lo th¢ ITUStees of the ch&Tity as follow&'. 2024 2023 Spe&kerfees rAueaiioiiAI pl￿gramIne Facilitsior Trnvel expenses 1,638 JO,876 700 8.810 2,132 lJ.642 Spcaker fccs wex paid 10 2 Trustett12023., 3) ftsT prepaTaiion alld $pe&king &t $ociety Study DAYS. Education ¢ndorseiii¢nl fees iver¢ paid lo O T￿Ste¢SI2023.. 0) for i'¢view work underlakell on educ31ional tnaterials as paTI of the Educational Endthsemerti offuiii Education Prograrnmc FatiliEatOT fecs ivtre ￿ld to l Tnjsiee for tA)nsultaiicy work on the or8aiiis&iion of 8iudy days aod other oi¥anisati￿7al work rcgarding Ilie aiinual conferences alld other charity S•W)¢es. Except 8s liS￿d above, no otlier reiiillnerglioll oi. expenses were paid loany Trustee during ihe year. 12 DEBTORS 2024 2025 Trgde debtors Amrtuiits due fi'nm Piiik@l>ink TVS Lld Prepa)menis and acti'ued ittconie 36,293 205,085 900 33.485 poo 244,278 148.556 13 CREDITORS.. AI%qOUNTS FALLING DUE WITHIN ONC YEAR 2024 Tthdc¢redili)TS Conference 2025- Iiel I'eceivable5 Corp(M?ie Partnership 2024-2025 A¢cruals al￿ defer￿J intome 1,515 101,719 L.53L J.513 35.999 149 138 57.512 TISSUE VIABILITY SOCIE'fY {TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEildBER 2024 ii. 14 UNRE,8'1'RICI'fD fiJNDS BIFivd lJJeDme oiidlture Tyaiisfej CIFwd Gaie¥al ful￿S 202,228 127,136 1136,459) 192,905 202,22 127 136 136 459 192905 IS RTr"tsTRWCTf,D fuND B/Fwd In¢ome ndlithi't Tr411$(ers Clwwd Educati￿1￿1 Gi'ants ree'd 2024 TVS Coiifei'ence 2024 Legs MRtter Skin Care Challipions STOP Ilie Pr¢ssur¢ 54,554 9,534 40,981 (2,353) {1.83J) 54,554 3,636 01,179 {9,.151) {4,070) 75,785 86,788 5,550 8,501b (81,683) {66,590) (12,548) (10,739) 100.885 176,623 {171.56111 105,948 Edu¢ationAI Gra￿19 The chaiiryreceives SPODSOtsbip thi'ough direct sponsorship or Ihiough ouriiered colp￿￿te inembeTship system 10 PTovide uyiits to liealihcare pmfts%ionals to eiiable tliein to all￿1d theTVS conferences Ènd exhibitiotis. The liealllicaie pi'ofesqionals ay Teceive a grant to cover Iravcl alld accomtnodation costs foT Ihe evcnl, a5 w¢ll a5 cov¢ring Ili¢ Cost of attcnding ihc events. TVS Coiiference Tlie cliaiity liolds an annu31 ¢onferen¢e eoveriiig a wide ra￿8¢of topi¢$ Iviihin the ieniii of the ¢barity ioenlaan¢e the k#owlcdBe aiid a¥varen&%£ nf tbesc taiiics f(x' liealtiicatr professional% across the eounliy. The ch&iityreLeivo% si%)nsorship and ?iilS 10 enable Ihis ¢onferen¢e 10 be held. Legs Maller Legs Matlyr is o coaliliort of orKanisaiioiis woikiiig togeiherro increase awareness. widerstandiixg and action on lower le8 aiid fool condilioiis aiiioiig Ilie public aiid liealihcare professioiials Ilirough year-¥ound activities and coininunicalions. Tlie chasily ieceives coipoi?le spoiisorsliip lo fund Iliis activity. Skiii C#re CliginpiDm$ Skin Cair Cliampions piovid¢5 p¢ople wotkiiig in ¢aiY li01n￿ and lioix¢ ¢are 48¢n¢ie8 a iJJsi¢d pro8r8mm¢ of ¢osi-¢ffe¢iive and easily accessibk education lo support skin health And ivound liealing. SiOP the Pi'¢ssure Slop'l'hc ljressurc aiins create & 8igntficant culture sliift aiid eliminatc avoidablc pressure ulcer% iii acul4 cominunity and mental liediih provider s¢rtin¥s Ilimugh 4 varieiy Or￿11VIlle9 to supJM)ri healiheare piYTrfessioiial. i]￿l￿dif18 Iiosting free wcbiiiars witli expeii s￿k￿3 leadiiig iiiforiiialive sessions. putting together training sessions foroiBanisalioiis and d￿r[OpIng 8raphi¢s and post￿3 wlii¢h b¢ adAPted lo¢ally 16 RELATED PARTIES Pink@Pink I"VS is a com￿nY r¢gi5tered in England gnd Wales Icoinpany Numkr.. 081998011 ivhich aets on bdialf o Tissue Viability Socieiy in Ilie oigalll$81ion aiid Inattagemeni of sevei?l of Ihe charity's fuods aitd eveilLS. ￿le ¢oihpary is cuiIEnlly owiied aiid iwnaged l)y illdividual% whojn 31e ijol Iiuslees of Ilie chaiity. The cliarity maintains OY￿sight Ot'lhe finaii¢ial dt41ings of Ili¢ ¢onipany Ihrough regular iiiaDagement rLyoning by the conipany tothc Ch￿￿ty. Listed bdoiv is an overall su]nmaiyof Ilic thi￿SactionS wlii¢li have beeD und¢rtaken on behalf of the Cliarity. 2024 In￿me 5%￿ndIture 36J,U48 270,132 90,916 370.056 425,302 (55.240 £J14,Y71 Al￿￿￿1l19 dDt fyom PliikOPlnk TVS Ltd_ Dlsclosed ivllliln Deblors TI,SSUE VIABII,ITY SOClb,'rY {TVS) NOTES TO THE FINANCIAI, SI'A'rr.Mfi NTS FOR THII YEAR F.NDED 31ST DFCTr.MIIF.R 2024 12. 17 ANALYSIS OF NET ASSLTS BETWEEN FUNDS Unresli-ictLd RestL'iCted 2024 As at 31 Decembei. 2024 Debtors Ilank and Casli Creditoi's 39,193 203,711 (45,888) {103,250 205,085 244,2711 203,713 (149,138) 197,018 101,835 298,853 Uni"¢sts'icted Resti'ictcd 2023 As at 31 December 2023 Debtors Bank and Cash Ciedilors 34,385 192,069 37,512 114,171 148,556 192,069 (37,512 188,942 114,171 303,113